Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • Affymetrix, Inc. (AFFX) Partners With Ingenuity Systems To Eradicate Microarray Expression Analysis Bottleneck 0 comments
    Apr 9, 2013 2:38 PM | about stocks: AFFX

    Affymetrix and Ingenuity Systems, a leader in providing biomedical information and analysis solutions, have announced they will co-promote Ingenuity iReport with Affymetrix expression microarray products. This will effectively eliminate a bottleneck for researchers working with human, mouse, and rat applications by combining a fast and accurate statistical analysis and biological interpretation workflow with this gold standard platform for gene expression studies.

    Ingenuity iReport is an interactive, Web-based report leveraging the Ingenuity Knowledge Base of biological and chemical findings from peer-reviewed literature and databases. When combined with Ingenuity iReport, Affymetrix expression microarrays - the standard methodology used in many research and study applications - provide researchers with "a sample to insight" continuous workflow, enabling rapid, confident interpretation of results without the necessity of bioinformatics experience or support.

    "We are excited to partner with Ingenuity Systems to provide our array users with access to the intuitive biological and statistical analysis platform offered by iReport," said Kevin Cannon, Ph.D., SVP - Expression Business Unit at Affymetrix. "Bundling together our robust expression microarrays with the iReport platform will provide Affymetrix customers with a simple and accurate tool to convert data into biologically relevant results."

    The University of Wisconsin's Department of Pediatrics was able to accelerate its data interpretation several times over, as compared with using other analysis tools, by leveraging Ingenuity iReport with Affymetrix gene expression arrays in its study on a mouse model of familial hypertrophic cardiomyopathy. The rapid and effectively blind analysis offered an unbiased validation of the data, and iReport additionally allowed the department to identify and explore genes of interest found with Affymetrix gene chips that had not yet been identified by other analysis tools.

    For more information, visit www.affymetrix.com

    Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

    Stocks: AFFX
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.